TP53 and breast cancer: Wang et al. [44] showed that the use of NS-C207895 in the breast-cancer cell line MCF-7 to inhibit the expression of MDMX can activate p53 and lead to the high expression of proapoptotic genes, thereby promoting the apoptosis of tumor cells.